123 related articles for article (PubMed ID: 7229378)
1. Immunologic control of the ascites form of murine adenocarcinoma 755. V. Antibody-directed macrophages mediate tumor cell destruction.
Langlois AJ; Matthews T; Roloson GJ; Thiel HJ; Collins JJ; Bolognesi DP
J Immunol; 1981 Jun; 126(6):2337-41. PubMed ID: 7229378
[TBL] [Abstract][Full Text] [Related]
2. Immunologic control of the ascites form of murine adenocarcinoma 755. IV. Characterization of the protective antibody in hyperimmune serum.
Matthews TJ; Collins JJ; Roloson GJ; Thiel HJ; Bolognesi DP
J Immunol; 1981 Jun; 126(6):2332-6. PubMed ID: 7229377
[TBL] [Abstract][Full Text] [Related]
3. Immunologic control of a retrovirus-associated murine adenocarcinoma. VI. Augmentation of antibody-dependent killing following quantitative and qualitative changes in host peritoneal cells.
Matthews TJ; Weinhold KJ; Langlois AJ; Bolognesi DP
J Natl Cancer Inst; 1985 Oct; 75(4):703-8. PubMed ID: 3862902
[TBL] [Abstract][Full Text] [Related]
4. Immunologic control of a retrovirus-associated murine adenocarcinoma. VII. Tumor cell destruction by macrophages and IgG2A.
Langlois AJ; Matthews TJ; Weinhold KJ; Bolognesi DP
J Natl Cancer Inst; 1985 Oct; 75(4):709-15. PubMed ID: 3862903
[TBL] [Abstract][Full Text] [Related]
5. Immunologic control of the ascites form of murine adenocarcinoma 755. III. Efficacy of serum therapy is controlled by a single genetic locus.
Roloson GJ; Haagensen DE; Chambers CA; Bolognesi DP
J Immunol; 1981 Jun; 126(6):2328-31. PubMed ID: 7229376
[TBL] [Abstract][Full Text] [Related]
6. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
[TBL] [Abstract][Full Text] [Related]
7. Specific surface antigens expressed on activated mouse peritoneal macrophages and recognized by a novel monoclonal antibody.
Someya A
Immunology; 1985 Dec; 56(4):683-8. PubMed ID: 3908293
[TBL] [Abstract][Full Text] [Related]
8. NK 1+ CD4- CD8- alphabeta T cells in the peritoneal cavity: specific T cell receptor-mediated cytotoxicity and selective IFN-gamma production against B cell leukemia and myeloma cells.
Sugie T; Kubota H; Sato M; Nakamura E; Imamura M; Minato N
J Immunol; 1996 Nov; 157(9):3925-35. PubMed ID: 8892624
[TBL] [Abstract][Full Text] [Related]
9. Impaired anti-tumor cytotoxicity of macrophages from osteopontin-deficient mice.
Bourassa B; Monaghan S; Rittling SR
Cell Immunol; 2004 Jan; 227(1):1-11. PubMed ID: 15051510
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies directed against mouse macrophages in different stages of activation for tumor cytotoxicity.
Taniyama T; Tokunaga T
J Immunol; 1983 Aug; 131(2):1032-7. PubMed ID: 6863926
[TBL] [Abstract][Full Text] [Related]
11. [The modelling of the growth of Ehrlich carcinoma and teratoma T-36 with ascitic fluid and tumor-cell dialysate].
Donenko FV; Kabieva AO; Moroz LV
Biull Eksp Biol Med; 1992 Jul; 114(8):193-5. PubMed ID: 1467492
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of in vivo tumor growth by a monoclonal IgM antibody recognizing tumor cell surface carbohydrates.
Gil J; Alvarez R; Viñuela JE; Ruiz de Morales JG; Bustos A; De la Concha EG; Subiza JL
Cancer Res; 1990 Nov; 50(22):7301-6. PubMed ID: 2224860
[TBL] [Abstract][Full Text] [Related]
13. Antibody-dependent lysis of tumor cells in vivo. II. Elimination of chromium-51 as a measurement of cytolysis.
Scornik JC; Klein PA
J Natl Cancer Inst; 1978 Oct; 61(4):1149-54. PubMed ID: 212569
[TBL] [Abstract][Full Text] [Related]
14. Modulatory effect of killed Propionibacterium acnes and its purified soluble polysaccharide on peritoneal exudate cells from C57Bl/6 mice: major NKT cell recruitment and increased cytotoxicity.
Ananias RZ; Rodrigues EG; Braga EG; Squaiella CC; Mussalem JS; Longhini AL; Travassos LR; Longo-Maugéri IM
Scand J Immunol; 2007 Jun; 65(6):538-48. PubMed ID: 17523946
[TBL] [Abstract][Full Text] [Related]
15. Differential inhibition of fluid accumulation and tumor growth in two mouse ascites tumors by an antivascular endothelial growth factor/permeability factor neutralizing antibody.
Luo JC; Toyoda M; Shibuya M
Cancer Res; 1998 Jun; 58(12):2594-600. PubMed ID: 9635584
[TBL] [Abstract][Full Text] [Related]
16. H-2 allele-specific protection from NK cell lysis in vitro for lymphoblasts but not tumor targets. Protection mediated by alpha 1/alpha 2 domains.
Sentman CL; Olsson MY; Salcedo M; Höglund P; Lendahl U; Käre K
J Immunol; 1994 Dec; 153(12):5482-90. PubMed ID: 7989750
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of macrophage function by 2-chloroadenosine.
Ohtani A; Kumazawa Y; Fujisawa H; Nishimura C
J Reticuloendothel Soc; 1982 Sep; 32(3):189-200. PubMed ID: 7153986
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of macrophage-induced cytotoxicity by phorbol ester tumor promoters.
Laskin DL; Laskin JD; Kessler FK; Weinstein IB; Carchman RA
Cancer Res; 1981 Nov; 41(11 Pt 1):4523-8. PubMed ID: 7306973
[TBL] [Abstract][Full Text] [Related]
19. [The effect of ascitic fluid on the growth of Ehrlich tumor and Lewis carcinoma].
Donenko FV; Kabieva AO; Moroz LV
Biull Eksp Biol Med; 1992 Jul; 114(8):191-3. PubMed ID: 1467491
[TBL] [Abstract][Full Text] [Related]
20. Antibody-dependent lysis of tumor cells in vivo. I. Early lysis of tumor cells.
Scornik JC; Klein PA
J Natl Cancer Inst; 1978 Oct; 61(4):1143-8. PubMed ID: 279715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
